Vatican Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vatican Technology Review.

Press releases published on June 4, 2026

Jun. 4, 2026

OT Group Ltd Provides Monthly Market Update and Private Equity Outlook

Indeterminate GlobeNewswire

Jun. 4, 2026

Global-e Announces Board Authorization of $500 Million Share Repurchase Program

Indeterminate GlobeNewswire

Jun. 4, 2026

AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society

Indeterminate GlobeNewswire

Jun. 4, 2026

Attralus Therapeutic Zamubafusp Alfa (AT-02) Receives U.S. FDA Orphan Drug Designation for the Treatment of AL Amyloidosis

Indeterminate GlobeNewswire

Jun. 4, 2026

Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026

Indeterminate GlobeNewswire

Jun. 4, 2026

Syndax Announces Private Placement of $250.0 Million of Convertible Senior Notes

Indeterminate GlobeNewswire

Jun. 4, 2026

Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO

Indeterminate GlobeNewswire

Jun. 4, 2026

Click Holdings Limited (CLIK) Reports Strong Q3 Operational Growth with 73% Revenue Increase

Indeterminate GlobeNewswire

Jun. 4, 2026

GH Research Announces Publication of Phase 2a Postpartum Depression Results

Indeterminate GlobeNewswire

Jun. 4, 2026

TVC Analyst Group Publishes Cybersecurity Watch List Ahead of Gartner Security & Risk Management Summit 2026

Indeterminate GlobeNewswire

Jun. 4, 2026

Ragnarok: Twilight Global Official Launching in Europe and North, Central and South America on June 4, 2026

Indeterminate GlobeNewswire

Jun. 4, 2026

Virtune informs about an update from index provider MarketVector regarding the underlying price source for index ETPs

Indeterminate GlobeNewswire

Jun. 4, 2026

Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®

Indeterminate GlobeNewswire

Jun. 4, 2026

DaltonTx launches its drug discovery platform, Dalton, and announces Sygnature Discovery collaboration

Indeterminate GlobeNewswire

Jun. 4, 2026

Sword Group: Strategic contract with eu-LISA

Indeterminate GlobeNewswire

Jun. 4, 2026

JioHotstar Deepens Partnership with Magnite to Advance Programmatic Monetisation and Mediation Across Live Sports and Entertainment Portfolio

Indeterminate GlobeNewswire

Jun. 4, 2026

Valneva Announces Availability of Documentation for its Annual General Meeting

Indeterminate GlobeNewswire

Jun. 4, 2026

Valneva annonce la mise à disposition de la documentation relative à son Assemblée Générale annuelle

Indeterminate GlobeNewswire

Jun. 4, 2026

Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS

Indeterminate GlobeNewswire

Jun. 4, 2026

EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus

Indeterminate GlobeNewswire